id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-280361-242yq90p	Emmanuel, Stip	Psychiatric adverse events with hydrochloroquine during COVID-19 Pandemic	2020-06-20		.txt	text/plain	1108	87	43	Psychiatric adverse events with hydrochloroquine during COVID-19 Pandemic. For instance, the FDA has authorized clinicians to prescribe chloroquine and hydroxychloroquine for patients admitted to hospital with covid-19, and in parallel there were warnings from scientific advisers that no randomized controlled trial has been completed to date to support the drugs' safety and efficacy in this COVID-19 population (Lenzer 2020 , Owens 2020 insomnia and psychomotor agitation. Chloroquine and hydroxychloroquine for the prevention or treatment of Novel Coronavirus Disease (COVID-19) in Africa: caution for inappropriate off-label use in healthcare settings Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Psychosis following chloroquine ingestion: a 10-year comparative study from a malaria-hyperendemic district of India Psychosis likely induced by hydropxychloroquine in a patient with chronic Q fever: a case report and clinically relevant review of pharmacology Toxic psychosis during chloroquine treatment Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection	./cache/cord-280361-242yq90p.txt	./txt/cord-280361-242yq90p.txt